Fulbourn Hospital

Cambridge CB21 5ER

0 studies enrolling now · 7 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Prader-Willi Syndrome

Studies at this site

• Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) — Running, not enrolling
• Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome — Running, not enrolling
• Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period — Completed
• A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome — Completed
• Proof-of-Concept Study of a Selective p38 MAPK Alpha Inhibitor, Neflamapimod, in Subjects With Mild Alzheimer's Disease — Completed
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed
• Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil — Stopped early